Zainab Contractor
Neurology · Cincinnati, OHNPI 1821088568
Payments from drug & device makers
Across 717 payments — averaging $251.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$93K
- Amgen$34K
- Teva Pharmaceuticals USA, Inc.$24K
- Noven Pharmaceuticals, Inc.$10K
- Biohaven Pharmaceuticals, Inc.$9K
- Biohaven Pharmaceutical Holding Company Ltd.$6K
- plus $5K from 29 others
What the payments were for
- Consulting fees$2500%
- Speaking & faculty fees$165,48892%
- Travel & lodging$3,9972%
- Food & beverage$10,8906%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 277 | $93,284 |
| Amgen | 65 | $34,301 |
| Teva Pharmaceuticals USA, Inc. | 77 | $23,569 |
| Noven Pharmaceuticals, Inc. | 9 | $9,857 |
| Biohaven Pharmaceuticals, Inc. | 31 | $8,828 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $6,284 |
| Noven Therapeutics, LLC | 16 | $1,613 |
| Supernus Pharmaceuticals, Inc. | 75 | $633 |
| Impel Pharmaceuticals Inc. | 26 | $339 |
| Lilly USA, LLC | 13 | $241 |
| Amneal Pharmaceuticals LLC | 18 | $219 |
| UCB, Inc. | 10 | $201 |
| Novartis | 15 | $193 |
| Pfizer | 10 | $166 |
| Collegium Pharmaceutical, Inc. | 8 | $153 |
| Upsher-smith Laboratories LLC | 6 | $108 |
| Lundbeck LLC | 4 | $80 |
| Sunovion Pharmaceuticals Inc. | 9 | $64 |
| Eisai Inc. | 3 | $63 |
| Biogen | 3 | $57 |
| Vertical Pharmaceuticals, LLC | 4 | $57 |
| Bausch Health US, LLC | 3 | $41 |
| Currax Pharmaceuticals LLC | 3 | $37 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Assertio Therapeutics, Inc. | 2 | $27 |
| Acadia Pharmaceuticals Inc | 2 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| Abbott | 1 | $21 |
| Corium, LLC | 2 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $12 |
| SK Life Science, Inc. | 1 | $12 |
| Biodelivery Sciences International, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$180,624 in reported general payments places this provider in the 85th percentile of 702 neurology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NeuproRotigotine | 14 | $11,479 |
| Clonidine Hcl ErClonidine Hcl | 13 | $1,826 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 20 | $1,329 |
| Methylphenidate Hcl | 39 | $1,313 |
| Gabapentin | 28 | $518 |
| Sumatriptan Succinate | 11 | $298 |
| Lamotrigine | 19 | $102 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $95 |
| Methocarbamol | 12 | $13 |
| Clonazepam | 13 | $0 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| UCB, Inc.Neupro | $201 | $11,47914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 702 neurology providers in Ohio.
Other neurology in Cincinnati
- Aram ZabetiCincinnati$5.3M
- Hani KushlafCincinnati$1.9M
- Alberto EspayCincinnati$785K
- Brandon ForemanCincinnati$677K
- Andrew DukerCincinnati$620K
- Michelle BowmanCincinnati$419K
- Joel VandersluisDayton$12.3M
- Jerry MendellColumbus$11.5M
- Lawrence GoldstickDayton$6.9M
- Douglas ScharreColumbus$6.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.